Article
Interleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917, a useful tool for prediction of therapy response in hepatitis C patients.
Journal of clinical microbiology - 1 Jul 2011
Fonseca-Coronado Salvador, Vaughan Gilberto, Cruz-Rivera Mayra Yolanda, Carpio-Pedroza Juan Carlos, Ruiz-Tovar Karina, Ruiz-Pacheco Juan Alberto, Escobar-Gutiérrez Alejandro
Abstract excerpt
Several studies have identified associations between single nucleotide polymorphisms (SNPs) occurring near the interleukin-28B (IL-28B) gene and response to antiviral treatment among hepatitis C virus (HCV) patients. Here, we describe a reliable melt-mismatch amplification mutation assay (melt-MAMA) PCR-based genotyping method for IL-28B which can be used in the management of HCV patients, helping to better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
